$AXON

SMITH PATRICK W sold $40K of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 70 shares of AXON ENTERPRISE, INC. (AXON) at $566.62 on 2026-08-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Aug 11, 2026, 8:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The CEO’s open-market sale under a pre-arranged 10b5-1 plan is a disclosed event that can slightly influence sentiment, but it is not a fundamental catalyst by itself.

02

Market read

Traders may note the insider selling datapoint, but the 10b5-1 designation and small transaction size suggest limited tradable impact.

03

What to watch

The filing does not include any new operational or financial information; without follow-on insider buys or guidance changes, the signal is mostly sentiment-based.

Relevance 2/10Novelty 3/10Timing: filed after-hours on 2026-08-11, reflecting the 2026-08-07 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

CEO Smith Patrick W filed a Form 4 open-market sale of 70 shares at $566.6186 on a 10b5-1 plan, reducing holdings to 3,030,997.

Expected impact

Likely minimal impact; any reaction should be short-lived unless accompanied by other fundamental news.

Evidence & confidence

The filing is a disclosed insider transaction under a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. The dollar amount ($39.7k) is small relative to company scale, so the market signal is likely muted.

Market effects

No direct sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Because it is a 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations, so traders may ignore it.

Key entities

  • AXON

    Axon Enterprise, Inc., the company whose CEO filed the Form 4 insider sale.

  • SMITH PATRICK W

    Chief Executive Officer and director who sold 70 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.